Top 5 Takeaways for Genitourinary Cancer Care From 2025 ASCO GU

The 2025 ASCO Genitourinary Cancers Symposium exhibited several updates in the management of various genitourinary cancers, with late-breaking abstract presentations and poster sessions alike highlighting potential advancements in the treatment of patients with bladder cancer, prostate cancer, kidney cancer, and other malignancies. These findings elucidated how modalities such as tyrosine kinase inhibitors and antiandrogen agents may continue to impact the treatment paradigm.